pubmed-article:17211638 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0019169 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0037140 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0240790 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0021745 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0021920 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0524909 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:17211638 | lifeskim:mentions | umls-concept:C0202086 | lld:lifeskim |
pubmed-article:17211638 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:17211638 | pubmed:dateCreated | 2007-2-7 | lld:pubmed |
pubmed-article:17211638 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17211638 | pubmed:abstractText | Intron 1 of the interferon-gamma (IFNG) gene contains two polymorphisms. The 12 CA-repeat allele of the +875 IFNGCA microsatellite and the T allele of the +A874T single nucleotide polymorphism (SNP) have been associated with increased in vitro IFNG production and a variety of clinical phenotypes. The purpose of this study was to determine whether these polymorphisms influence total serum IgE levels [tsIgE] and the outcome of a hepatitis B virus (HBV) infection. IFNGCA and +A874T were typed in 186 asthmatics of Niuean ancestry and in Polynesian women with a chronic HBV infection (n = 60) and with natural immunity to the HBV (n = 66). The IFNGCA genotype was associated with [tsIgE] in asthmatic children (n = 51, p = 0.004) but not adults (n = 135, p = 0.87). The data were consistent with a co-dominant influence of the 12 CA-repeat allele on high [tsIgE]. The IFNGCA genotype was also associated with the risk for chronic HBV infection (chi (2) = 11.6, p = 0.003) because of a dominant effect of the 12 CA-repeat allele on developing natural immunity in homozygotes (OR = 5.8, p = 0.003) and heterozygotes (OR = 2.7, p = 0.01). Similar associations were found for the T allele of the +A874T SNP. The possibility that these associations were due to linked alleles in the adjacent 783 bp of the promoter and 3'-untranslated region of the IFNG gene was excluded by direct sequencing. In summary, high-IFNG-producing alleles in intron 1 of the IFNG locus are associated with high [tsIgE] in asthmatic children from Niue and with natural immunity to the HBV in Polynesian women. These findings are consistent with a previous report of an association between +875 IFNGCA and [tsIgE] and provide preliminary evidence of a new association with the outcome of an HBV infection. | lld:pubmed |
pubmed-article:17211638 | pubmed:language | eng | lld:pubmed |
pubmed-article:17211638 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17211638 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17211638 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17211638 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17211638 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17211638 | pubmed:month | Mar | lld:pubmed |
pubmed-article:17211638 | pubmed:issn | 0093-7711 | lld:pubmed |
pubmed-article:17211638 | pubmed:author | pubmed-author:TukuitongaCol... | lld:pubmed |
pubmed-article:17211638 | pubmed:author | pubmed-author:WinshipIngrid... | lld:pubmed |
pubmed-article:17211638 | pubmed:author | pubmed-author:AbbottWilliam... | lld:pubmed |
pubmed-article:17211638 | pubmed:author | pubmed-author:GaneEdwardE | lld:pubmed |
pubmed-article:17211638 | pubmed:author | pubmed-author:MunnStephenS | lld:pubmed |
pubmed-article:17211638 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17211638 | pubmed:volume | 59 | lld:pubmed |
pubmed-article:17211638 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17211638 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17211638 | pubmed:pagination | 187-95 | lld:pubmed |
pubmed-article:17211638 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:meshHeading | pubmed-meshheading:17211638... | lld:pubmed |
pubmed-article:17211638 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17211638 | pubmed:articleTitle | Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians. | lld:pubmed |
pubmed-article:17211638 | pubmed:affiliation | New Zealand Liver Transplant Unit, Auckland City Hospital, Private Bag 92-024, Auckland, New Zealand. wghabbott@yahoo.com | lld:pubmed |
pubmed-article:17211638 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17211638 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:3458 | entrezgene:pubmed | pubmed-article:17211638 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17211638 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17211638 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17211638 | lld:pubmed |